Exploring the benefits and safety of combining nebivolol and valsartan for managing hypertension: a systematic review. [PDF]
BMC Cardiovasc DisordKhalid M +7 more
europepmc +1 more source
Discovery of potential AXL inhibitors using virtual screening, molecular docking, molecular dynamics, molecular mechanics, and in vitro validation. [PDF]
Sci RepSahin N +5 more
europepmc +1 more source
Early Detection of Nebivolol-Induced Hepatotoxicity. [PDF]
Eur J Case Rep Intern MedTorunova AM, Kireeva VV, Kurganskii IS.
europepmc +1 more source
Development of pH-Sensitive β‑Adrenergic Receptor Antagonists. [PDF]
ACS Pharmacol Transl SciBraun T +4 more
europepmc +1 more source
Nebivolol Inhibits Hepatocellular Carcinoma via RHOQ and Enhances the Efficacy of Lenvatinib. [PDF]
Int J Biol SciZhang S +15 more
europepmc +1 more source
Metabolic Disturbances Associated with Beta-Blocker Therapy: New Insights from a Large-Scale Pharmacovigilance Study. [PDF]
Pharmaceuticals (Basel)Solomon CC +11 more
europepmc +1 more source
Protective Effect of Esmolol on the Hypertensive Aortic Wall Persists After Withdrawal of Short-Term Treatment. [PDF]
J Clin MedFernández-Morales D +8 more
europepmc +1 more source
Protective effects of beta-blockers against anthracycline- and trastuzumab-related cardiotoxicity: a systematic review based on conventional and Bayesian network meta-analysis. [PDF]
Front Cardiovasc MedJiang S, Gao G.
europepmc +1 more source
Comparative Effectiveness and Outcomes of Nebivolol Versus Other Beta Blockers in Patients With Hypertension: A Multicenter Cohort Study. [PDF]
J Am Heart AssocChang YC +4 more
europepmc +1 more source